Thierry Conroy

20.9k total citations · 7 hit papers
147 papers, 9.7k citations indexed

About

Thierry Conroy is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thierry Conroy has authored 147 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 54 papers in Surgery and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thierry Conroy's work include Pancreatic and Hepatic Oncology Research (33 papers), Colorectal Cancer Treatments and Studies (31 papers) and Colorectal Cancer Surgical Treatments (29 papers). Thierry Conroy is often cited by papers focused on Pancreatic and Hepatic Oncology Research (33 papers), Colorectal Cancer Treatments and Studies (31 papers) and Colorectal Cancer Surgical Treatments (29 papers). Thierry Conroy collaborates with scholars based in France, United Kingdom and Netherlands. Thierry Conroy's co-authors include Olivier Bouché, Michel Ducreux, Laurent Bedenne, Valérie Boige, Jane Blazeby, Orhan Sezer, Jean‐Pierre Pignon, Marc Ychou, Éric François and P. Rougier and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Thierry Conroy

140 papers receiving 9.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

2011 1.5k citations Marc Ychou, Valérie Boige et al. Journal of Clinical Oncology profile →
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203

2006 1.3k citations Thierry Conroy, Franck Bonnetain et al. Journal of Clinical Oncology profile →
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2015 941 citations Michel Ducreux, Thomas Seufferlein et al. Annals of Oncology profile →
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

2016 653 citations Thierry Conroy et al. profile →
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

2014 276 citations Thierry Conroy, Jean‐Luc Raoul et al. profile →
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2023 190 citations Thierry Conroy, Per Pfeiffer et al. Annals of Oncology profile →
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

2024 57 citations Thierry Conroy, Florence Castan et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Thierry Conroy

Since Specialization

Citations

This map shows the geographic impact of Thierry Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Conroy more than expected).

Fields of papers citing papers by Thierry Conroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Conroy. The network helps show where Thierry Conroy may publish in the future.

Co-authorship network of co-authors of Thierry Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Conroy. A scholar is included among the top collaborators of Thierry Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Conroy. Thierry Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acceptability and usefulness of the EORTC ‘Write In three Symptoms/Problems’ (WISP): a brief open-ended instrument for symptom assessment in cancer patients 2024 ·Health and Quality of Life Outcomes ·(unknown), (unknown), Thierry Conroy, (unknown), Monica Guberti, Bernhard Holzner, Olga Husson, Dagmara Kuliś, Omar Shamieh, Claire Piccinin, (unknown), Gudrun Rohde, Mogens Grøenvold, (unknown)	3
2	Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial 2023 ·Journal of the National Comprehensive Cancer Network ·Cindy Neuzillet, Olivier Bouché, Christophe Tournigand, Benoist Chibaudel, (unknown), Leïla Bengrine-Lefèvre, (unknown), May Mabro, Jean‐Philippe Metges, Denis Péré-Vergé, Thierry Conroy, Astrid Lièvre, (unknown), Françoise Desseigne, François Goldwasser, Julie Henriques, Amélie Anota, Pascal Hammel	13
3	Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up breakdown → 2023 ·Annals of Oncology ·Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Ángela Lamarca, Thomas Seufferlein, Eileen M. O’Reilly, Thilo Hackert, Talia Golan, Gerald W. Prager, Karin Haustermans, Arndt Vogel, Michel Ducreux	190
4	COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) 2023 ·Cancers ·Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, (unknown), Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, M. Bellanger, Jean‐Luc Raoul	2
5	Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis 2023 ·European Journal of Cancer ·Caroline Mollévi, Sophie Gourgou, Christophe Borg, Pierre-Luc Etienne, Emmanuel Rio, Éric Rullier, Béata Juzyna, Florence Castan, Thierry Conroy	22
6	When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials 2023 ·BMC Medical Research Methodology ·Célia Touraine, (unknown), Thierry Conroy, Béata Juzyna, Sophie Gourgou, Caroline Mollévi	3
7	Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial 2022 ·Cancers ·(unknown), Julia Salleron, Thierry Conroy, Frédéric Marchal, (unknown), Laure Monard, James Biagi, Aurélien Lambert	3
8	COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19) 2022 ·Cancers ·Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, (unknown), Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, M. Boisdron‐Celle, M. Bellanger, Jean‐Luc Raoul	2
9	Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study 2021 ·Cancers ·Ke Zhou, Audrey Blanc-Lapierre, Valérie Seegers, M. Boisdron‐Celle, Frédéric Bigot, (unknown), Hakim Mahammedi, Aurélien Lambert, Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, M. Bellanger, Jean‐Luc Raoul	6
10	Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer 2021 ·Cancers ·Aurélien Lambert, Lilian Schwarz, Michel Ducreux, Thierry Conroy	24
11	Future directions in drug development in pancreatic cancer 2021 ·Seminars in Oncology ·Aurélien Lambert, Thierry Conroy, Michel Ducreux	12
12	Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results 2020 ·Quality of Life Research ·Caroline Mollévi, (unknown), C. Bourgier, Thierry Conroy, Bruno Chauffert, Mohamed Hebbar, William Jacot, Béata Juzyna, Hélène de Forges, Sophie Gourgou, Franck Bonnetain, Célia Touraine, Amélie Anota	10
13	The impact of physical activity on fatigue and quality of life during and after adjuvant treatment for breast cancer 2017 ·Cancer ·Florian Manneville, Christine Rotonda, Thierry Conroy, Franck Bonnetain, Françis Guillemin, Abdou Y. Omorou	15
14	Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial breakdown → 2011 ·Journal of Clinical Oncology ·Marc Ychou, Valérie Boige, Jean‐Pierre Pignon, Thierry Conroy, Olivier Bouché, G. Lebreton, (unknown), Laurent Bedenne, (unknown), B. Saint‐Aubert, Jean Genève, P Lasser, P. Rougier	1484
15	ゲムシタビンを含む処方で以前に治療された進行膵癌患者におけるラロタキセルと5-FU(5-FUまたはカペシタビンの連続的血管内投与)を比較する第3相試験 2010 ·Annals of Oncology ·(unknown), Teresa Macarulla, (unknown), Félix Couture, Marc Peeters, (unknown), (unknown), (unknown), (unknown), Thierry Conroy	3
16	Factors correlated with fatigue in breast cancer patients before, during and after adjuvant chemotherapy: The FATSEIN study 2010 ·Contemporary Clinical Trials ·Christine Rotonda, F. Guillemin, Franck Bonnetain, Thierry Conroy	12
17	Development of an EORTC module for the assessment of cancer related fatigue (EORTC FAR-15): Phase III results. 2007 ·UCL Discovery (University College London) ·John R. Weis, Yan-Li Gao, Thierry Conroy, Susanne Singer, Eva Hammerlid, Bernhard Holzner, Claudia Fleissner, Fabio Efficace, Juan Ignacio Arrarás, (unknown), Hans‐Henning Flechtner, Anne Lanceley, Louise Jones	1
18	Activity of vinorelbine in gastrointestinal cancers 2002 ·Critical Reviews in Oncology/Hematology ·Thierry Conroy	12
19	Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study 1997 ·Annals of Oncology ·D. Peiffert, Jean‐François Seitz, P. Rougier, Éric François, F. Cvitkovic, X. Mirabel, (unknown), Michel Ducreux, Jean‐Michel Hannoun‐Lévi, A. Lusinchi, (unknown), Thierry Conroy, Jean‐Pierre Pignon, J.P. Gérard	46
20	Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin 1994 ·American Journal of Clinical Oncology ·Thierry Conroy, P Cappelaere, Michel Fabbro, A. A. Fauser, T. A. W. Splinter, M. Spielmann, Martina Schneider, B Chevallier, A Goupil, J Chauvergne, P. Fargeot, (unknown), Paul O’Grady, (unknown), J. Hardenberg, Malcolm Boyce	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact